Oncotelic Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OTLC research report →
About the company
Oncotelic Therapeutics, Inc. , an Agoura Hills, California-based clinical-stage biopharmaceutical company, specializes in developing therapeutics for rare oncological conditions. Its flagship therapeutic candidate, OT-101 – an antisense compound designed to inhibit TGF-ß2 – is currently undergoing Phase 3 clinical trials for both pancreatic cancer and glioblastoma.
- CEO
- Vuong Trieu
- IPO
- 1993
- Employees
- 26
- HQ
- Agoura Hills, CA, US
Price Chart
- Market Cap
- $17.74M
- P/E
- 0.07
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 48.68
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 0.00%
- ROIC
- -0.00%
- Revenue
- $0 · 0.00%
- Net Income
- $249.28M · 105.51%
- EPS
- $0.59 · 5367.86%
- Op Income
- $-3,186,599
- FCF YoY
- -186843971.13%
- 52W High
- $0.11
- 52W Low
- $0.02
- 50D MA
- $0.05
- 200D MA
- $0.07
- Beta
- -0.27
- Avg Volume
- 279.62K
Get TickerSpark's AI analysis on OTLC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 1, 26 | Trieu Vuong | buy | 240,000 |
| Jun 24, 26 | Trieu Vuong | buy | 115,000 |
| Jun 23, 26 | Trieu Vuong | buy | 75,000 |
| Jun 22, 26 | Trieu Vuong | buy | 65,000 |
| Jun 22, 26 | Shah Amit B. | buy | 20,000 |
| Jun 17, 26 | Trieu Vuong | buy | 239,759 |
| Jun 15, 26 | Trieu Vuong | buy | 96,000 |
| Jan 22, 26 | Trieu Vuong | other | 4,426 |
| Nov 17, 25 | Trieu Vuong | other | 4,065 |
| Jul 8, 25 | Trieu Vuong | buy | 94,736 |
Our OTLC coverage
Recent articles, reports, and earnings notes.
No research on OTLC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OTLC report →Similar companies
Peers in the same neighborhood.